12 Mar
Lords Chamber
Apricity Fertility Closure

The House of Lords session centered on the closure of Apricity Fertility, a digital IVF clinic, which affected many undergoing treatment. The debate highlighted the regulatory challenges faced by the Human Fertilisation and Embryology Authority (HFEA), emphasizing the need to adapt its powers to include new digital service models. Speakers underscored the complexities of navigating unregulated fertility services and the wider context of private versus NHS-funded fertility treatments.

2023

The year the HFEA published 'Modernising Fertility Law' report with recommendations for urgent change.

Outcome

The session concluded with a commitment from the Government to further examine the regulatory landscape, consider legislative reforms, and address disparities in access to fertility services across the UK. The need for modernized fertility laws was acknowledged to ensure the safety and fairness for all patients.

Key Contributions

Baroness Owen of Alderley Edge
Conservative

Queried about the Government’s assessment of Apricity’s closure on patients and highlighted its lack of regulation.

Baroness Merron
Labour

Referenced HFEA’s 'Modernising Fertility Law' and the Government’s evaluation of HFEA's priorities.

Lord Winston
Labour

Criticized Apricity’s misleading advertising of success rates.

Baroness Barker
Liberal Democrats

Advocated for a legislative review to update the 1990 fertility laws.

Lord Kamall
Conservative

Discussed discrepancies in access to fertility services highlighted in the Women’s Health Strategy.

Baroness Deech
Crossbench

Addressed the problem of increased commercialization in fertility services.

Baroness Manzoor
Conservative

Highlighted the outdated legislation not reflective of current patient expectations and service delivery.

Original Transcript
Baroness Owen of Alderley Edge

To ask His Majesty’s Government what assessment they have made of the effect of the closure of Apricity Fertility on 1 January on the patients who were undertaking treatment with them.

The Parliamentary Under-Secretary of State, Department of Health and Social Care
Baroness Merron
Lab

My Lords, the Human Fertilisation and Embryology Authority advised the department about the closure of Apricity in December. Apricity did not fall under the HFEA’s regulatory remit, as it was only a digital service.

I urge anyone seeking fertility treatment to check that the clinic they are using is HFEA licensed. I advise affected patients in this case to check their consumer rights and engage with trading standards, if needed. More broadly, the HFEA is helpfully providing advice.

Baroness Owen of Alderley Edge
Con

My Lords, Apricity Fertility advertised itself as: “The UK’s Top Virtual IVF Clinic”.

As the Minister pointed out, it was not regulated by the Human Fertilisation and Embryology Authority, which by law can regulate only UK-licensed fertility clinics, which are the premises where treatments take place.

Will the Minister commit to a review of the HFEA’s powers to ensure they are appropriate for digital services?

Baroness Merron
Lab

As the noble Baroness will be aware, in November 2023 the HFEA published Modernising Fertility Law, in which it made a number of recommendations for urgent change, including around its regulatory powers.

I will meet the HFEA chair and CEO tomorrow, and we will further discuss the regulatory challenges that the HFEA faces.

I assure the noble Baroness that the Government are currently considering the HFEA’s priorities, including its role with digital clinics such as the one referred to, should an opportunity for legislative reform arise.

Baroness Merron
Lab

My noble friend raises an extremely important point, which I will of course cover in my meeting tomorrow.

It may be of interest to know that the Advertising Standards Authority and the HFEA issued a joint enforcement notice in 2021 to ensure that fertility clinics and others were aware of the advertising rules and were treating consumers fairly. That remains in place.

The ASA periodically reviews compliance with its rules. Its recent review in the fertility sector found far fewer absolute claims than it had found previously and that the level of compliance is good. That is not to say that it is good in all cases, and I agree with my noble friend’s point.

Baroness Barker
LD

My Lords, the law governing human fertilisation and embryology in this country built on the outstanding work of Baroness Warnock.

It was carefully crafted so that it rests on principles that endure, but it was designed in such a way that it could be regularly updated to deal with advances in scientific knowledge and changes in society.

Does the Minister agree that this is an indication that we have come to a point where that legislation needs to be reviewed? In order to do that, will the Government commit to beginning the process of consultation that must take place before any legislative review comes to this Chamber?

Baroness Merron
Lab

I agree with the noble Baroness’s observations. The legislation goes back to 1990.

We are in 2025, and there has been an advent of many new technologies, techniques and business models—for example, the noble Baroness, Lady Owen, referred to Apricity—that were never imagined just a few years ago, let alone in 1990. The majority of clinics are privately owned.

Many are part of large groups with external finance. Elements of fertility care and associated treatments are increasingly offered online or outside HFEA regulation. There is a huge challenge here. That is why we are in discussion with the HFEA, and we will be in discussion tomorrow.

Lord Kamall
Con

My Lords, the Minister will recall that in 2022 the previous Government published the 10-year Women’s Health Strategy for England.

During the consultation process, it came out that access to fertility services differs greatly across the country—possibly one of the reasons that many women went to Apricity in the first place.

Part of the solution that was proposed to tackle these disparities was a target to establish women’s health hubs. I understand that the current Government have decided not to go ahead with these women’s health hubs.

My question is not why, but how the Government envisage tackling these disparities without women’s health hubs. What is the strategy for doing that?

Baroness Deech
CB

My Lords, I declare an interest as a former chair of the HFEA. The problem the Minister has referred to is increasing commercialisation. Vulnerable patients are more or less captured by clinics—for example, by being charged ever-increasing amounts for the storage of their embryos.

How can the Government get to grips with the market element in an area that is largely private? Can they encourage the NHS? I know the difficulty of taking on more. What legislation can there be to control this commercialisation and the huge amount earned by the private doctors?

Baroness Merron
Lab

The noble Baroness and other noble Lords are quite right in what they are reporting on the change. Fertility treatment is now overwhelmingly obtained through private means. It is in a very different place from the rest of healthcare in our country.

On the point the noble Baroness made—I am grateful for her contribution in view of her previous service in this area—there are many claims made, for example, about egg freezing.

It is crucial that anyone considering freezing their eggs understands that there is an optimum age for freezing, that it is a serious medical procedure and that the risks should be taken into account. That chimes with the point made by my noble friend Lord Winston.

The market has changed—it has very much become a market. The demand is huge and has multiplied many times over the decades. We are not in a situation where we have either the regulation or the NHS provision to deal with that.

I assure your Lordships’ House that we are working with NHS England, particularly on the variability up and down the country.

Baroness Manzoor
Con

My Lords, the Minister is right that the market has changed, but the legislation has not been kept up to date; nor has it kept up to date with patient expectations, developments and the way those services are being provided for some of these women. Often, some of these women are vulnerable.

Can the Minister say exactly what the Government will do to update not only the regulations but the law?

All content derived from official parliamentary records